TITRATION OF INTRAMUSCULAR INTERFERON BETA-1A REDUCES THE SEVERITY AND INCIDENCE OF FLU-LIKE SYMPTOMS

被引：0
|
作者：
Matson, M. [1 ]
Zimmerman, T. R., Jr. [2 ]
Sperling, B. [2 ]
Tuccillo, D. [2 ]
Tang, T. [2 ]
Deykin, A. [2 ]
机构：
[1] PRISM Res, St Paul, MN USA
[2] Biogen Idec Inc, Weston, MA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2011年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：529 / 529
页数：1
相关论文
共 50 条
  • [41] Utilization and safety of intramuscular interferon beta-1a in the post-marketing setting
    Hyde, R.
    Curnow, K.
    Foulds, P.
    Richman, S.
    Friend, S.
    Glick, G.
    Onigman, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 493 - 493
  • [42] Injection of interferon-beta in the morning decreases flu-like syndrome in many patients with multiple sclerosis
    Nadjar, Yann
    Coutelas, Emilie
    Prouteau, Pauline
    Panzer, Fabienne
    Paquet, Daniele
    Saint-Val, Claude
    Creange, Alain
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (04) : 316 - 322
  • [43] Real-world outcomes in patients with relapsing forms of multiple sclerosis treated with intramuscular interferon beta-1a or peginterferon beta-1a
    Salter, A.
    Lancia, S.
    Cutter, G.
    Fox, R.
    Marrie, R. A.
    Avila, R.
    Vignos, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 187 - 187
  • [44] Real-world characterisation of peginterferon beta-1a associated flu-like symptoms and injection site reactions and impact of mitigation strategies coached in an individualized patient support program in Germany
    Niemczyk, G.
    Begus-Nahrmann, Y.
    Washeim, N.
    Trundler, M. -T.
    Naylor, M. L.
    Maeurer, M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 496 - 496
  • [45] Imiquimod/interferon-α-2bSevere local skin reaction and flu-like symptoms: case report
    Reactions Weekly, 2009, 1245 (1) : 21 - 21
  • [46] Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis
    Rudick, RA
    Simonian, NA
    Alam, JA
    Campion, M
    Scaramucci, JO
    Jones, W
    Coats, ME
    Goodkin, DE
    Weinstock-Guttman, B
    Herndon, RM
    Mass, MK
    Richert, JR
    Salazar, AM
    Munschauer, FE
    Cookfair, DL
    Simon, JH
    Jacobs, LD
    NEUROLOGY, 1998, 50 (05) : 1266 - 1272
  • [47] Pregnancy Outcomes in Patients Exposed to Intramuscular Interferon beta-1a (IM IFNβ-1a)
    Tomczyk, Sylvie
    Sperling, Bjorn
    NEUROLOGY, 2013, 80
  • [48] Effects of statins on intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis
    Rudick, R.
    Pace, A.
    Panzara, M.
    Rani, S.
    Schrock, J.
    Calabresi, F.
    Confavreux, C.
    Galetta, S.
    Lublin, F.
    Radue, E. W.
    Stuart, W.
    Weinstock-Guttman, B.
    Wynn, D.
    MULTIPLE SCLEROSIS, 2007, 13 : S57 - S57
  • [49] Final Results from the AVONEX® (Intramuscular Interferon Beta-1a) Pregnancy Exposure Registry
    Richman, Sandra
    Wallace, Katrina
    Liu, Shifang
    Sperling, Bjorn
    NEUROLOGY, 2012, 78
  • [50] Characteristics and clinical outcomes of underserved minority patients with multiple sclerosis treated with peginterferon beta-1a or intramuscular interferon beta-1a in MS PATHS
    Hersh, Carrie M.
    Fitzgerald, Kathryn
    Ryerson, Lana Zhovtis
    Mowry, Ellen
    Liao, Shirley
    Altincatal, Arman
    Naylor, Maria
    NEUROLOGY, 2021, 96 (15)
12345